- Home
- PAR vs CPRX Comparison
PAR vs CPRX Comparison
Compare PAR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- CPRX
- Stock Information
- Founded
- PAR 1968
- CPRX 2002
- Country
- PAR United States
- CPRX United States
- Employees
- PAR N/A
- CPRX N/A
- Industry
- PAR Office Equipment/Supplies/Services
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- PAR Miscellaneous
- CPRX Health Care
- Exchange
- PAR Nasdaq
- CPRX Nasdaq
- Market Cap
- PAR 2.7B
- CPRX 2.9B
- IPO Year
- PAR N/A
- CPRX 2006
- Fundamental
- Price
- PAR $69.06
- CPRX $21.81
- Analyst Decision
- PAR Strong Buy
- CPRX Strong Buy
- Analyst Count
- PAR 7
- CPRX 6
- Target Price
- PAR $79.86
- CPRX $32.83
- AVG Volume (30 Days)
- PAR 431.1K
- CPRX 1.4M
- Earning Date
- PAR 08-07-2025
- CPRX 08-06-2025
- Dividend Yield
- PAR N/A
- CPRX N/A
- EPS Growth
- PAR N/A
- CPRX 178.13
- EPS
- PAR N/A
- CPRX 1.57
- Revenue
- PAR $383,768,000.00
- CPRX $534,645,999.00
- Revenue This Year
- PAR $30.06
- CPRX $16.37
- Revenue Next Year
- PAR $16.97
- CPRX $8.80
- P/E Ratio
- PAR N/A
- CPRX $13.93
- Revenue Growth
- PAR 37.95
- CPRX 29.97
- 52 Week Low
- PAR $43.50
- CPRX $15.34
- 52 Week High
- PAR $82.24
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- PAR 58.95
- CPRX 42.36
- Support Level
- PAR $65.57
- CPRX $20.62
- Resistance Level
- PAR $70.89
- CPRX $22.06
- Average True Range (ATR)
- PAR 1.98
- CPRX 0.66
- MACD
- PAR 0.23
- CPRX 0.03
- Stochastic Oscillator
- PAR 79.49
- CPRX 56.67
About PAR PAR Technology Corporation
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).